Related Experiment Video
Updated: Feb 8, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
New and Evolving Immunotherapy in Inflammatory Bowel Disease.
Mohamad A Raad1, Nour H Chams1, Ala I Sharara2
1School of Medicine, American University of Beirut, Beirut, Lebanon.
Inflammatory bowel disease (IBD) involves immune system dysregulation. Understanding these complex mechanisms offers opportunities for developing novel, targeted therapies beyond current treatments like anti-TNF biologics.
Area of Science:
- Gastroenterology and Immunology
- Molecular Biology
- Genetics
Background:
- Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases (IBD) stemming from immune dysregulation against gut microbes in susceptible individuals.
- IBD pathogenesis is intricate, marked by substantial heterogeneity in disease presentation and genetic factors.
Purpose of the Study:
- To explore the complex molecular and immunological underpinnings of inflammatory bowel disease.
- To identify potential targets for novel therapeutic strategies in IBD management.
Main Methods:
- Review of recent genetic and immunological discoveries in IBD.
- Analysis of aberrant host-microbe interactions and immune signaling pathways.
Main Results:
- Unraveled abnormalities include impaired mucosal defense, increased intestinal permeability, and dysregulated antigen processing.
- Identified issues in cellular immune regulation, cytokine production, and leukocyte trafficking.
Conclusions:
- Current IBD treatments (anti-TNF biologics, immunosuppressants, surgery) have limitations, highlighting an unmet need.
- Understanding these molecular pathways is crucial for developing next-generation targeted IBD therapies.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Tumor Immunotherapy

